Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis

INTRODUCTION: In stage IV NSCLC with solitary or oligometastatic brain metastasis, surgical resection of the primary and definitive management of the brain metastasis is an accepted standard. However, the effect of systemic chemotherapy after surgical resection on overall survival is not well-establ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vedire, Yeshwanth R., Shin, Sarah, Groman, Adrienne, Hennon, Mark, Dy, Grace K., Yendamuri, Sai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238748/
https://www.ncbi.nlm.nih.gov/pubmed/37275564
http://dx.doi.org/10.1016/j.jtocrr.2023.100522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238748/
https://www.ncbi.nlm.nih.gov/pubmed/37275564
http://dx.doi.org/10.1016/j.jtocrr.2023.100522

Ejemplares similares